Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1

Interventions

pembrolizumab 512 Specimen Handling 381 Carboplatin 371 Magnetic Resonance Spectroscopy 333 Cisplatin 327 Nivolumab 302 Cyclophosphamide 295 Radiotherapy 254 Paclitaxel 252 Biopsy 235 Gemcitabine 229 Bevacizumab 212 Dexamethasone 167 durvalumab 162 Oxaliplatin 160 Capecitabine 154 Rituximab 151 Fluorouracil 148 venetoclax 142 atezolizumab 141 Docetaxel 141 Drug Therapy 140 Etoposide 138 Doxorubicin 131 Ipilimumab 125 Radiosurgery 118 Lenalidomide 117 Prednisone 116 Leucovorin 111 fludarabine 109

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Synapsins × 1 year × Clear all

NCT07332351 2026-03-13

TRIFECTA

University of Washington

Phase 2 Not yet recruiting

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡